Toll-like receptor 4 signaling complex (TLR4 complex)

The Toll-like receptor 4 (TLR4) signaling complex is a central mediator of the innate immune response, primarily recognized for its role in detecting lipopolysaccharide (LPS) from Gram-negative bacteria (Park et al., 2009, Nature). The functional complex involves the TLR4 transmembrane protein associated with myeloid differentiation factor 2 (MD-2) and cluster of differentiation 14 (CD14), which together coordinate the recognition and binding of microbial ligands (Akira et al., 2004, Nature Reviews Immunology). Activation of the complex triggers downstream signaling through MyD88 and TRIF adapters, resulting in the expression of pro-inflammatory cytokines and type I interferons (Lu et al., 2008, Cytokine). While essential for host defense, overactivation of TLR4 is a primary driver of septic shock and has been linked to chronic inflammatory conditions, autoimmune diseases, and cancer progression (Ciesielska et al., 2021, Molecular Cancer). Therapeutic strategies targeting the TLR4 complex include small molecule inhibitors like Resatorvid and lipid A analogs like Eritoran, which aim to mitigate hyper-inflammation (Opal et al., 2013, JAMA). Conversely, TLR4 agonists such as Monophosphoryl lipid A are utilized as adjuvants in vaccines to enhance the adaptive immune response (Needham et al., 2013, Expert Review of Vaccines).

Other names

TLR4/MD-2 complexCD284LY94Toll-like receptor 4LPS receptor complex

Antagonism of the MD-2 binding site to prevent lipopolysaccharide-induced dimerization and signaling, or agonism to stimulate innate immunity for use as vaccine adjuvants.